1. Home
  2. RCKT vs USCB Comparison

RCKT vs USCB Comparison

Compare RCKT & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • USCB
  • Stock Information
  • Founded
  • RCKT 1999
  • USCB 2002
  • Country
  • RCKT United States
  • USCB United States
  • Employees
  • RCKT N/A
  • USCB N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • USCB Major Banks
  • Sector
  • RCKT Health Care
  • USCB Finance
  • Exchange
  • RCKT Nasdaq
  • USCB Nasdaq
  • Market Cap
  • RCKT 340.9M
  • USCB 324.4M
  • IPO Year
  • RCKT N/A
  • USCB 2021
  • Fundamental
  • Price
  • RCKT $3.03
  • USCB $17.15
  • Analyst Decision
  • RCKT Buy
  • USCB Strong Buy
  • Analyst Count
  • RCKT 13
  • USCB 3
  • Target Price
  • RCKT $12.88
  • USCB $22.00
  • AVG Volume (30 Days)
  • RCKT 1.9M
  • USCB 32.1K
  • Earning Date
  • RCKT 11-06-2025
  • USCB 10-23-2025
  • Dividend Yield
  • RCKT N/A
  • USCB 2.26%
  • EPS Growth
  • RCKT N/A
  • USCB 50.85
  • EPS
  • RCKT N/A
  • USCB 1.57
  • Revenue
  • RCKT N/A
  • USCB $92,331,000.00
  • Revenue This Year
  • RCKT N/A
  • USCB $26.26
  • Revenue Next Year
  • RCKT $3,582.16
  • USCB $13.21
  • P/E Ratio
  • RCKT N/A
  • USCB $11.26
  • Revenue Growth
  • RCKT N/A
  • USCB 28.61
  • 52 Week Low
  • RCKT $2.19
  • USCB $15.39
  • 52 Week High
  • RCKT $15.01
  • USCB $21.12
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 37.29
  • USCB 44.36
  • Support Level
  • RCKT $3.10
  • USCB $17.40
  • Resistance Level
  • RCKT $3.37
  • USCB $18.23
  • Average True Range (ATR)
  • RCKT 0.20
  • USCB 0.38
  • MACD
  • RCKT -0.07
  • USCB -0.01
  • Stochastic Oscillator
  • RCKT 7.73
  • USCB 12.20

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.

Share on Social Networks: